This September San Diego s Stratify Genomics Inc. announced Prompt a test to evaluate a man s genetic predisposition to prostate cancer designed to provide knowledge of an individual s baseline prostate cancer risk. While we aren t sure when such a test might touch the Indian shores but on a global platform we think this is going to be a great achievement in diagnosis and screening of prostate cancer. Experts say that prostate cancer is highly curable and treatable when diagnosed in the early stages. This is why it is essential that men know about the risks and